DAVID MCKENNA: Open Payments
NPI 1215538913 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 12 payments from 9 companies in 2025. Trend: 2023 $190 · 2024 $347 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ABBVIE INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MOUNJARO, FARXIGA, CAPLYTA, GVOKE HYPOPEN, INSPIRE, LEQVIO, UBRELVY, HETLIOZ.
Industry payments across SC — which companies pay providers there.
